TREATMENTS &
RESEARCH

Search the
latest
treatment
information
here.

Dr. Huntley's
Diagnosis
Checklist

Have a symptom?
See what questions
a doctor would ask.
 
Diseases » Chlamydia pneumoniae » Treatments
 

Treatments for Chlamydia pneumoniae

Chlamydia pneumoniae: Marketplace Products, Discounts & Offers

Products, offers and promotion categories available for Chlamydia pneumoniae:

Chlamydia pneumoniae: Research Doctors & Specialists

Research all specialists including ratings, affiliations, and sanctions.

Hospitals & Medical Clinics: Chlamydia pneumoniae

Research quality ratings and patient incidents/safety measures for hospitals and medical facilities in specialties related to Chlamydia pneumoniae:

Hospital & Clinic quality ratings » »

Choosing the Best Treatment Hospital: More general information, not necessarily in relation to Chlamydia pneumoniae, on hospital and medical facility performance and surgical care quality:

Buy Products Related to Treatments for Chlamydia pneumoniae

 
Shopping.com


Book Excerpts: Treatment of Chlamydia pneumoniae

Treatments of Chlamydia pneumoniae: Online Medical Books

16 MEDICAL BOOKS ONLINE! Review excerpts from medical books online, free, without registration, for more information about the treatments of Chlamydia pneumoniae.

Acute pneumonia: Treatment (Tx)
(Professional Guide to Diseases (Eighth Edition))

Antibiotics, oxygen, mechanical ventilation, increased fluid intake, bed rest, analgesics

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Pneumonia: Treatment
(Professional Guide to Diseases (Eighth Edition))

Antimicrobial therapy varies with the causative agent. Therapy should be reevaluated early in the course of treatment. Supportive measures include humidified oxygen therapy for hypoxemia, mechanical ventilation for respiratory failure, a high-calorie diet and adequate fluid intake, bed rest, and an analgesic to relieve pleuritic chest pain. Patients with severe pneumonia on mechanical ventilation may require positive end-expiratory pressure to facilitate adequate oxygenation.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Pneumocystis carinii pneumonia: Treatment
(Professional Guide to Diseases (Eighth Edition))

PCP may respond to drug therapy with co-trimoxazole. Other agents used to treat PCP include pentamidine, trimethoprim-dapsone, clindamycin, primaquine, and atovaquone. Corticosteroids are frequently used as well. However, because of immune system impairment, many patients with PCP, who also have HIV, experience severe adverse reactions to drug therapy.

Supportive measures, such as oxygen therapy, mechanical ventilation, adequate nutrition, and fluid balance, are important adjunctive therapies. Oral morphine sulfate solution may reduce the respiratory rate and anxiety, thereby enhancing oxygenation.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Idiopathic bronchiolitis obliterans with organizing pneumonia: Treatment
(Professional Guide to Diseases (Eighth Edition))

Corticosteroids are the current treatment for BOOP, although the ideal dosage and duration of treatment remain topics of discussion. Relapse is common when steroids are tapered off or stopped. This usually can be reversed when steroids are increased or resumed. Occasionally, a patient may need to continue corticosteroids indefinitely.

Immunosuppressive-cytotoxic drugs, such as cyclophosphamide, have been used in the few cases of intolerance or unresponsiveness.

Oxygen is used to correct hypoxemia. The patient may need either no oxygen or a small amount of oxygen at rest and a greater amount when he exercises.

Other treatments vary, depending on the patient’s symptoms, and may include inhaled bronchodilators, cough suppressants, and bronchial hygiene therapies.

BOOP is very responsive to treatment and usually can be completely reversed with corticosteroid therapy. However, a few deaths have been reported, particularly in patients who had more widespread pathologic changes in the lung or patients who developed opportunistic infections or other complications related to steroid therapy.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Vitamin C deficiency: Treatment
(Professional Guide to Diseases (Eighth Edition))

Because scurvy is potentially fatal, treatment begins immediately to restore adequate vitamin C intake by daily doses of 100 to 200 mg vitamin C in synthetic form or in orange juice in mild disease and by doses as high as 500 mg/day in severe disease. Symptoms usually subside in 2 to 3 days; hemorrhages and bone disorders, in 2 to 3 weeks.

To prevent vitamin C deficiency, patients unable or unwilling to consume foods rich in vitamin C or those facing surgery should take daily supplements of ascorbic acid. The recommended daily allowance is 60 mg/day. Vitamin C supplementation may also prevent this deficiency in recently weaned infants or those drinking formula not fortified with vitamin C.

» READ BOOK EXCERPT ONLINE »

Source: Professional Guide to Diseases (Eighth Edition), 2005

Pneumonia: Treatment
(Handbook of Diseases)

Antimicrobial therapy varies with the causative agent. Therapy should be reevaluated early in the course of treatment.

Supportive measures include humidified oxygen therapy for hypoxia, mechanical ventilation for respiratory failure, a high-calorie diet and adequate fluid intake, bed rest, and an analgesic to relieve pleuritic chest pain. Patients with severe pneumonia on mechanical ventilation may require positive end-expiratory pressure to facilitate adequate oxygenation.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Pneumocystis carinii pneumonia: Treatment
(Handbook of Diseases)

PCP may respond to drug therapy with trimethoprim-sulfamethoxazole. Because of immune system impairment, many patients with HIV experience adverse reactions to drug therapy; diphenhydramine may be prescribed to reduce these adverse effects.

Pentamidine may be administered I.V. or in aerosol form. I.V. pentamidine is associated with a high incidence of severe toxic effects; the inhaled form is usually well tolerated. However, inhaled pentamidine may not effectively reach the lung apices. Adverse reactions associated with inhalation include metallic taste, pharyngitis, cough, bronchospasm, shortness of breath, rhinitis, and laryngitis.

Supportive measures, such as oxygen therapy, mechanical ventilation, adequate nutrition, and fluid balance, are important adjunctive therapies.

CLINICAL TIP: Oral or I.V. morphine sulfate may reduce the respiratory rate and anxiety, thereby enhancing oxygenation.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Bronchiolitis obliterans with organizing pneumonia, idiopathic: Treatment
(Handbook of Diseases)

Corticosteroids are the treatment of choice for BOOP, although the ideal dosage and duration of treatment remain topics of discussion. In most cases, treatment begins with 1 mg/kg/day of prednisone for at least several days to several weeks; the dosage is then gradually reduced over several months to a year, depending on the patient’s response. Relapse is common when the steroid dosage is tapered off or stopped but usually can be reversed when the dosage is increased or resumed. Occasionally, a patient may need to continue corticosteroid therapy indefinitely.

Immunosuppressant-cytotoxic drugs, such as cyclophosphamide, have been used in the few cases in which the patient couldn’t tolerate or was unresponsive to corticosteroids.

Oxygen is used to correct hypoxemia. The patient may need either no oxygen or a small amount of oxygen at rest and a greater amount when he exercises.

Other treatments vary, depending on the patient’s symptoms, and may include an inhaled bronchodilator, a cough suppressant, and bronchial hygiene therapy.

BOOP is responsive to treatment and usually can be completely reversed with corticosteroid therapy. However, a few deaths have been reported, particularly in patients who had more widespread pathologic changes in the lungs or patients who developed opportunistic infections or other complications related to steroid therapy.

» READ BOOK EXCERPT ONLINE »

Source: Handbook of Diseases, 2003

Assure coverage for resistantStreptococcus pneumoniae with vancomycin if there is a concernfor meningitis: Management of Bacterial Meningitis
(Avoiding Common Pediatric Errors)

The broad-spectrum cephalosporins, cefotaxime and ceftriaxone, have traditionally been used as standard therapy for bacterial meningitis in infants and children. However, in the past decade, penicillin-and cephalosporin- resistant pneumococcal meningitis has been reported. In fact, cultures of cerebrospinal fluid (CSF) were positive for 3 to 14 days after the initiation of therapy. Therefore, in an attempt to identify an effective therapy, several antibiotic regimens including vancomycin, chloramphenicol, rifampin, erythromycin, and imipenem, alone and in combination were given to patients to identify an ideal anti–pneumococcal meningitis regimen.

Researchers concluded that on the basis of data from the pneumococcal meningitis models and limited clinical experience, it was impossible to make a single recommendation for initial empiric treatment that would be suitable forallpatientswithsuspectedorprovenpneumococcalmeningitis.However, the following guidelines could be considered in managing such patients:
• Physicians should be aware of the S. pneumoniae susceptibility patterns in their area and request their hospital laboratories to perform dilution susceptibility tests on any pneumococcal isolates recovered from usually sterile body sites.
• Because penicillin-resistant pneumococci have been identified in many areas of the United States, initial empiric therapy for bacterial meningitis should be based on the possibility that it is the etiology of the patient's illness. The recommended therapy is therefore ceftriaxone or cefotaxime and vancomycin (60 mg/kg/day divided in four doses), in addition to dexamethasone.
• A repeat lumbar puncture in patients with pneumococcal meningitis to document eradication of the pathogen should be performed 24 to 36 hours after the start of therapy, primarily in patients in whom the organism is cephalosporin resistant.
• Alteration of the initial antimicrobial regimen should be based on the clinical response of the patient and on the results of the CSF culture and susceptibility studies from the second lumbar puncture. In the event that the patients' clinical condition has worsened or that the follow-up Gram- stained smear or culture of CSF indicates failure to substantially reduce or eradicate the organism, substitution of rifampin for vancomycin in the therapeutic regimen is recommended.
• Patients without complications should be treated for a minimum of 10 days.

» READ BOOK EXCERPT ONLINE »

Source: Avoiding Common Pediatric Errors, 2008

Community-acquired Pneumonia: Management
(Pediatric Infectious Disease)

The management of the febrile tachypneic neonate suspected of having pneumonia is similar to that of neonatal fever. Empiric intravenous antibiotics are started until culture results are final. Empiric treatment usually consists of ampicillin combined with gentamicin or a third-generation cephalosporin. Treatment of C. trachomatis is with oral erythromycin, 50 mg/kg per day in four divided doses for 2 weeks. In the past, erythromycin was given to neonates exposed to C. trachomatis at the time of delivery. Recently, there has been an association reported between oral erythromycin and the subsequent development of hypertrophic pyloric stenosis in infants younger than 6 weeks of age. The current recommendation is to treat with oral erythromycin, 50 mg/kg per day in four divided doses for 14 days all infants with chlamydial conjunctivitis and pneumonia. Patients who are exposed at the time of delivery are not presumptively treated, but rather monitored closely for the development of disease. Routine screening of all pregnant women for sexually transmitted disease is helpful in reducing disease by C. trachomatis.

» READ BOOK EXCERPT ONLINE »

Source: Pediatric Infectious Disease, 2004



 » Next page: Doctors and Medical Specialists for Chlamydia pneumoniae

Rate This Website

What do you think about the features of this website? Take our user survey and have your say:

Website User Survey

Medical Tools & Articles:

Next articles:

Tools & Services:

Medical Articles:

Forums & Message Boards

 
HONcode We subscribe to the HONcode principles

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise